BioSpace News Archive

Drug Development

COVID-19 Vaccines Drive Q3 Revenue for Moderna and Pfizer

Both Moderna and Pfizer reported third-quarter financials this week, and it was instantly obvious that the COVID-19 vaccines are huge profit drivers for the companies.

November 4, 2021
·
3 min read
·
Mark Terry
Genetown

COVID-19 Update: UK Approves Molnupiravir, WHO Authorizes Ocugen/Bharat Vaccine

Merck and Ridgeback Biotherapeutics’ antiviral drug molnupiravir, which showed great promise against COVID-19 in clinical trials, received its first authorization.

November 4, 2021
·
3 min read
·
Mark Terry
Policy

Federal COVID-19 Vaccine Mandate Issued for Private Employers, Health Care Facilities

Vaccinations will be required by January 4 under the new White House plan.

November 4, 2021
·
3 min read
·
Alex Keown
Business

Novartis Sells Shares Back to Roche for $20.7 Billion

For the past 20 years, Novartis has held a 33% stake in Roche, its Basel, Switzerland neighbor. Now, Novartis has divested its one-third stake to Roche for a whopping $20.7 billion.

November 4, 2021
·
2 min read
·
Alex Keown
Genetown

Origin of Alzheimer’s Could Differ from Accepted Theories

Researchers with the University of Cambridge in the UK for the first time leveraged human data to quantify the speed of various processes in the brain that lead to Alzheimer’s disease.

November 4, 2021
·
5 min read
·
Mark Terry
Business

Four Biopharmas Rake in Funds for Novel Therapeutics

The proceeds will be used to advance the development of their ePLC platform, treatment for chronic Hepatitis B, and a novel class of anti-cancer therapies.

November 4, 2021
·
4 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, Nov. 5

Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

November 4, 2021
·
7 min read
·
Alex Keown
Business

Zymergen Eliminates 220 Jobs in Restructuring Push

The job cuts, which affect a variety of functions and levels, are expected to slow its cash burn rate and leave the company with sufficient funds on hand to operate until mid-2023.

November 4, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Research Roundup: New Insights into Alzheimer’s Progression and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

November 4, 2021
·
5 min read
·
Mark Terry
Business

AdaptHealth Announces Third Quarter 2021 Financial Results, Raises Full-Year 2021 Guidance, and Provides Full-Year 2022 Guidance

AdaptHealth Corp., a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced financial results for the third quarter ended September 30, 2021.

November 4, 2021
·
21 min read